Type2 Diabetes Clinical Trial
Official title:
Metabolomics Determinant of Postprandial Metabolism Following Meal-Challenge Test in Diabetes State Using NMR-based Metabolomics Approach
Postprandial hyperglycemia is a hallmark feature of Type 2 Diabetes Mellitus (T2D), and persistent elevated glycemic level has shown to be strongly associated with oxidative stress, and a risk factor for cardiovascular disease (CVD). In Malaysia, the glycemic control is poor and patients with T2D commonly experiencing persistent postprandial hyperglycemia (12.7 mmol/L). A low glycemic index (GI) meal has been reported to reduce postprandial glycemia and insulin concentration in patients with T2D. Metabolomics technique can be used to identify comprehensive metabolites in response to different diet. Till date, local scientific data documented on the role and interaction between diet and metabolites for the Malaysian patients with T2D is unknown. This study is to determine the postprandial metabolomic effect of low and high GI meals in patients with T2D using the NMR-based metabolomics approach. Then, patients with T2D will be assigned for 14 days of chronic feeding trial intervention. This study will help to establish local baseline data and understand the impact of meal-patterns on metabolic and metabolite at postprandial responses.
Despite targeting to optimize fasting blood glucose and lowering HbA1c level, postprandial
hyperglycemia needs to be highlighted in the management of Type 2 Diabetes Mellitus (T2D).
Postprandial hyperglycemia is the rapid and significant rise in blood glucose level above 7.8
mmol/L 2 hour after meal ingestion. It is strongly associated with oxidative stress and a
risk factor for cardiovascular disease (CVD).
In Malaysia, the glycemic control is poor, and patients with T2D commonly experiencing
persistent hyperglycemia (12.7 mmol/L), which is the highest concentration in South East Asia
region. Nonetheless, a low glycemic index (GI) meal has been reported to reduce postprandial
glycemia and insulin concentration in patients with T2D but the metabolite responsiveness
following low GI meal is not studied yet. The study of the postprandial state is imperative
as it reveals multiple aspects of metabolic health that would not be apparent from solely
studying the fasting parameters.
Hence, the objective of this study is to determine the postprandial metabolomic effects of
low and high GI meals in patients with T2D using the NMR-based metabolomics approach. Then,
the postprandial metabolic response and metabolomic profiles before and after the 14 days
chronic feeding trial intervention will be determined and compared. The calculated sample
size was 24 patients with T2D and 24 healthy individuals. The study design for meal challenge
test (MCT) is a single-blinded, randomized crossover trial with 1-week washout period;
whereas a case-control design will be used to compare metabolomic profiles of patients with
T2D and healthy individuals.
The MCT model is designed to be high GI (63) and low GI (46) with similar caloric value.
During the test day, participants are required to consume the meal within 15 minutes and the
blood sample will be taken at the following time points: 0min (fasting), 30, 60, 120, 180 and
240 min. Meanwhile, the urine sample will also be collected at 0, 60 and 240 min accordingly.
The blood sample will be analyzed for blood glucose, insulin, GLP-1, and metabolites; while
the urine sample will be analyzed for metabolites. The findings of this study are able to
provide fundamental data on metabolic responsiveness of T2D patients following specific
meal-plan tailored to Malaysian meal pattern using NMR-based metabolomics approach. Besides,
this study is able to establish a local baseline data of postprandial metabolite profiles of
patients with T2D following a specific meal plan. At the same time, this study contributes
insight to improve diabetes meal-plan that is friendly to postprandial metabolic
perturbations.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03239366 -
A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population
|
Phase 2 | |
Completed |
NCT04597229 -
Efficacy of Multigrain Supplementation in Type II Diabetes Mellitus
|
N/A | |
Completed |
NCT03623139 -
Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes
|
N/A | |
Active, not recruiting |
NCT04599920 -
Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life)
|
N/A | |
Active, not recruiting |
NCT03422471 -
Hypoglycemia and Autonomic Nervous System Function- B2
|
N/A | |
Completed |
NCT04382521 -
A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions
|
N/A | |
Recruiting |
NCT04564391 -
Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins
|
N/A | |
Recruiting |
NCT03458715 -
The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin
|
Phase 4 | |
Terminated |
NCT03278236 -
Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?
|
N/A | |
Completed |
NCT02974504 -
Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)
|
Phase 4 | |
Completed |
NCT05053828 -
Type 2 Diabetes With Antiplatelet Drugs
|
||
Not yet recruiting |
NCT03659383 -
The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine
|
Phase 4 | |
Completed |
NCT03542240 -
Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome
|
N/A | |
Completed |
NCT03657537 -
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
|
Phase 1 | |
Completed |
NCT03979768 -
Risk Assessment of Type 2 Diabetes in Pharmacies
|
N/A | |
Completed |
NCT03614039 -
Effect of Probiotic and Smectite Gel on NAFLD
|
N/A | |
Active, not recruiting |
NCT04994288 -
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03290768 -
Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)
|
N/A | |
Enrolling by invitation |
NCT04088851 -
"The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes"
|
N/A | |
Completed |
NCT03643783 -
Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients
|